Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 5, 2003, Pages 1247-1253

  Kim, Jun Sang ^a   Kim, Jae Sung ^a,b   Kim, Sam Yong ^a   Kim, Ki Hwan ^a   Cho, Moon June ^a  

^a Chungnam National University   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

Cervical cancer; Concurrent chemotherapy; Hyperfractionated radiotherapy; Para aortic lymph node recurrence

Indexed keywords

CHEMOTHERAPY; DOSIMETRY; RADIOTHERAPY; TOXICITY;

HYPERFRACTIONATED RADIOTHERAPY;

ONCOLOGY;

CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; ISOLATION PROCEDURE; LYMPH NODE; METASTASIS; NAUSEA; NEUROLOGIC DISEASE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RELAPSE; UTERINE CERVIX CARCINOMA;

EID: 0037376118     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04401-2     Document Type: Article

References (29)

1. Berman M.L., Keys H., Creasman W., et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 19:1984;8-16.
2. Manetta A., Delgado G., Petrilli E., et al. The significance of paraaortic node status in carcinoma of the cervix and endometrium. Gynecol Oncol. 23:1986;284-290.
3. Grigsby P.W., Perez C.A., Chao K.S., et al. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 49:2001;733-738.
4. Grigsby P.W., Vest M.L., Perez C.A. Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy. Int J Radiat Oncol Biol Phys. 28:1994;451-455.
5. Chatani M., Matayoshi Y., Masaki N., et al. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol. 171:1995;655-660.
6. Rotman M., Pajak T.F., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA. 274:1995;387-393.
7. Rotman M., Choi K., Guse C., et al. Prophylactic irradiation of the para-aortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920. Int J Radiat Oncol Biol Phys. 19:1990;513-521.
8. Haie C., Pejovic M.H., Gerbaulet A., et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 11:1988;101-112.
9. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
10. Piver M.S., Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 46:1975;507-510.
11. Podczaski E., Stryker J.A., Kaminski P., et al. Extended-field radiation therapy for carcinoma of the cervix. Cancer. 66:1990;251-258.
12. Cunningham M.J., Dunton C.J., Corn B., et al. Extended-field radiation therapy in early-stage cervical carcinoma Survival and complications. Gynecol Oncol. 43:1991;51-54.
13. Chou H.H., Wang C.C., Lai C.H., et al. Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int J Radiat Oncol Biol Phys. 51:2001;442-448.
14. Micke O., Prott F.J., Schafer U., et al. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer. Anticancer Res. 20:2000;5113-5115.
15. Kim S., Choi D., Kang S., et al. Clinical significance of squamous cell carcinoma associated antigen in patients with invasive carcinoma of uterine cervix. J Korean Cancer Assoc. 20:1988;153-159.
16. Cho M., Kim J., Park S., et al. Value of squamous cell carcinoma associated antigen (TA-4) in patients with invasive carcinoma. J Korean Soc Ther Radiol. 11:1993;397-401.
17. Hall E.J. Radiobiology for the radiologist; Time, dose, and fractionation in radiotherapy. 4th ed:1994;221-222 J.B. Lippincott Co, Philadelphia.
18. Faria S.L., Ferringno R. Hyperfractionated external radiation therapy in stage IIIB carcinoma of uterine cervix A prospective pilot study. Int J Radiat Oncol Biol Phys. 38:1997;137-142.
19. Varghese C., Rangad F., Jose C.C., et al. Hyperfractionation in advanced carcinoma of the uterine cervix A preliminary report. Int J Radiat Oncol Biol Phys. 23:1992;393-396.
20. Matthews R.H. Paraaortic lymph node metastasis as a sole site of failure from cervix cancer Curable or incurable disease? Int J Radiat Oncol Biol Phys. 28:1993;509.
21. Maneo A., Landoni F., Cormio G., et al. Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma. Ann Oncol. 10:1999;803-807.
22. Zanetta G., Torri W., Bocciolone L., et al. Factors predicting response to chemotherapy and survival in patients with metastatic or recurrent squamous cell cervical carcinoma A multivariate analysis. Gynecol Oncol. 58:1995;58-63.
23. Sommers G.M., Grigsby P.W., Perez C.A., et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol. 35:1989;150-155.
24. Rowinsky E.K., Cazenave L.A., Donehower R.C. Taxol A novel investigational antimicrotubule agent. J Natl Cancer Inst. 82:1990;1247-1259.
25. McGuire W.P., Blessing J.A., Moore D., et al. Paclitaxel has moderate activity in squamous cervix cancer A Gynecologic Oncology Group study. J Clin Oncol. 14:1996;792-795.
26. Cerrotta A., Gardan G., Cavina R., et al. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose. Eur J Gynaecol Oncol. 23:2002;115-119.
27. Rodriguez M., Sevin B.U., Perra J., et al. Paclitaxel A radiation sensitizer of human cervical cancer cells. Gynecol Oncol. 57:1995;165-169.
28. Geard C.R., Jones J.M. Radiation and taxol effects on synchronized human cervical cancer cell. Int J Radiat Oncol Biol Phys. 29:1994;565-569.
29. Nelson J.H. Jr, Boyce J., Macasaet M., et al. Incidence, significance, and follow-up of para-aortic lymph node metastases in late invasive carcinoma of the cervix. Am J Obstet Gynecol. 128:1977;336-340.